This is the latest episode of the free DDW narrated podcast, “Drug discovery trends: From regulation to embracing AI", which covers two articles written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: From the Editor: Law and order and How AI in pharma can live up to the hype. In the first article, DDW Editor Reece Armstrong comments on the post-Covid industry landscape. In the second article, Ben Folwell, Principal Consultant at Citeline, maps out how AI, swarm learning and open access to clinical data could revolutionise drug discovery ..read more

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The breaking news this week was certainly the first regulatory approval for Casgevy, not only the first gene therapy approved for sickle cell disease, but also the first therapy to use CRISPR gene editing. However, there were a number of other breakthroughs announced in the cell and gene therapy field. You can listen below, or find The Drug Discovery World Podcast on ..read more

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  With the first DDW Turning Science into Business Summit taking place next week on the theme of Cancer Research, this dynamic area of drug discovery is this week's round-up focus again. Most significantly, this week has seen the UK approval of a new indication for anastrozole in the prevention of breast cancer and a number of significant findings in the field of ..read more

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this episode, Megan Thomas is in conversation with Isaac Klein, Chief Scientific Officer of Dewpoint Therapeutics. Klein is a physician-scientist and medical oncologist. Throughout his career, Klein has sought to deploy novel biology and technology to better understand human disease and guide therapeutic development. He has extensively studied the intersection of condensate sc ..read more

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The news highlights this week feature a variety of exciting clinical trial results and launches that are examining therapies for much-needed disease areas, new drug approvals and even a space mission with a pharma twist. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.  ..read more

This is the latest episode of the free DDW narrated podcast, “Important therapies for the future of immunotherapy", which covers two articles written for Volume 23, Issue 3 – Summer 2022 of DDW. They are called “Improving quality control for CAR T cell therapies”, and “The importance of LAG-3 to the future of immunotherapy”. The first article includes insight from Mark White, Associate Director of Biopharma Product Marketing at Bio-Rad and Marwan Alsarraj, Biopharma Segment Manager, Digital Biology Group. The second article is an interview between Lu Rahman and Frederic Triebel, CSO, Immutep ..read more

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  To celebrate DDW’s first Turning Science into Business Summit on ‘Cancer research opportunities and advances’, the news round-up this week highlights the latest developments in oncology drug discovery. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.  ..read more

This is the latest episode of the free DDW narrated podcast, “Drug discovery success stories", which covers two articles written for Volume 23, Issue 3 – Summer 2022 of DDW. They are called “Global pharma start-up success stories”, and “Excitement at rectal cancer immunotherapy breakthrough”. In the first article, Lu Rahman selects some interesting global start-ups pushing the boundaries in drug discovery, from AI to £D deep-learning research to biologics. In the second article, we explore a groundbreaking ‘immuno-ablative’ neo- adjuvant immunotherapy clinical trial that Memorial Sloan Ketteri ..read more

The latest sponsored DDW Sitting Down With podcast features Professor Jonathan Blackburn, Chief Scientific Officer of Sengenics, who discusses the advantages of functional protein microarrays, challenges to overcome for biomarker discovery, Sengenics’ new i-Ome Discovery chip, and more.  As CSO, Professor Blackburn heads the R&D and product development strategy. He invented the patented Sengenics K-REX technology, holds more than 30 technology patents, and has published more than 130 peer reviewed papers, plus 9 book chapters. He serves on several committees, including the FNIH Steeri ..read more

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The buzz with week has been around Phase I trials, with new therapies for lung cancer, geographic atrophy, Parkinson’s, sarcopenia and long Covid demonstrating positive early results or entering clinical trials for the first time. You can find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.  ..read more